Spironolactone in diuretic regimens with meralluride or thiazides for pseudointractable ascites of cirrhosis.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001835:Body Weight / Q000187:drug effects; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000494:pharmacology / Q000627:therapeutic use*; D004338:Drug Combinations; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009941:Organomercury Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D013148:Spironolactone / Q000494:pharmacology / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D013829:Thiadiazines / Q000627:therapeutic use; D013997:Time Factors
D004232:Diuretics; D004338:Drug Combinations; D009941:Organomercury Compounds; D013449:Sulfonamides; D013829:Thiadiazines; D013148:Spironolactone